Amicar and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Amicar (aminocaproic acid), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Pantoprazole, and have Haemorrhage.

The phase IV clinical study analyzes which people have Weakness when taking Amicar. It is created by eHealthMe based on reports of 1,317 people who have side effects when taking Amicar from the FDA, and is updated regularly.

What is Amicar?

Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.

What is Weakness?

Weakness is found to be associated with 3,630 drugs and 6,554 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 16, 2025

1,317 people reported to have side effects when taking Amicar.
Among them, 36 people (2.73%) have Weakness.

Among these 36 people:

How long have people been on Amicar when they have Weakness? *

What is the gender of people who have Weakness when taking Amicar? *

female: 38.24 %
male: 61.76 %

What is the age of people who have Weakness when taking Amicar? *

What are other drugs people take besides Amicar? *

What are other side effects people have besides Weakness? *

Thrombocytopenia (decrease of platelets in blood): 24 people, 66.67%
Anaemia (lack of blood): 20 people, 55.56%
Dyspnea (difficult or laboured breathing): 19 people, 52.78%
Stress And Anxiety: 15 people, 41.67%
Arrhythmias (irregular heartbeat): 14 people, 38.89%
Hypotension (abnormally low blood pressure): 13 people, 36.11%
Diarrhea: 13 people, 36.11%
Death: 12 people, 33.33%
White Blood Cell Count Decreased: 12 people, 33.33%
Haemorrhage (bleeding): 12 people, 33.33%

What are the existing conditions these people have? *

Haemorrhage (bleeding): 11 people, 30.56%
High Blood Cholesterol: 10 people, 27.78%
Aortic Valve Incompetence: 10 people, 27.78%
Breast Cancer Metastatic: 10 people, 27.78%
Nausea (feeling of having an urge to vomit): 7 people, 19.44%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 6 people, 16.67%
Anaesthesia: 5 people, 13.89%
Thrombocytopenia (decrease of platelets in blood): 5 people, 13.89%
Respiratory Disorder (respiratory disease): 5 people, 13.89%
Pain In Extremity: 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amicar and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amicar:

Amicar (1,323 reports)

Weakness treatments and more:

Weakness (586,859 reports)

Browse all side effects of Amicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,630 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,554 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Amicar) and Amicar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.